Process evaluation and early outcomes of real-world implementation of a pharmacist-driven cabotegravir/rilpivirine long-acting injectable initiative

被引：1
|
作者：
Derrick, Caroline B. [1 ]
Magee, Matthew [2 ]
Tsai, Y. Vivian [3 ]
Pizzuti, Morgan E. [4 ]
Parker, Sarah [2 ]
Lucas, Omar [1 ]
Taylor, Kara [5 ]
Albright, Raeghan [6 ]
Langehans, Briley [7 ]
Schreiber, Danny [8 ]
Guest, Georgia [8 ]
Ahuja, Divya [1 ]
Weissman, Sharon [1 ]
机构：
[1] SC Univ South Carolina, Sch Med Columbia, Prisma Hlth Richland Columbia, Columbia, SC 29208 USA
[2] Univ South Carolina, Sch Med Columbia, Columbia, SC USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Prisma Hlth Richland Columbia, Columbia, SC USA
[5] WakeMed Hlth Raleigh, Raleigh, NC USA
[6] Publix Pharm Columbia, Columbia, SC USA
[7] Trident Med Ctr Charleston, Charleston, SC USA
[8] Univ South Carolina, Coll Pharm Columbia, Columbia, SC USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2024年
关键词：
cabotegravir; HIV-1; human immunodeficiency virus; pharmacist; resistance; rilpivirine; VIROLOGICAL FAILURE; HIV-1; INFECTION; RILPIVIRINE;
D O I：
10.1093/ajhp/zxae260
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Michael G. Sension
    Laurence Brunet
    Ricky K. Hsu
    Jennifer S. Fusco
    Quateka Cochran
    Christine Uranaka
    Gayathri Sridhar
    Vani Vannappagari
    Jean Van Wyk
    Lewis McCurdy
    Michael B. Wohlfeiler
    Gregory P. Fusco
    Infectious Diseases and Therapy, 2023, 12 : 2807 - 2817
  • [22] Injectable Long-Acting Cabotegravir-Rilpivirine Therapy for People Living With HIV/AIDS: Addressing Implementation Barriers From the Start
    Pinto, Rogerio M.
    Hall, Evan
    Tomlin, Ryan
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2023, 34 (02): : 216 - 220
  • [23] Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida
    Fisk-Hoffman, Rebecca J.
    Ranger, Sashaun S.
    Gracy, Abigail
    Gracy, Hannah
    Manavalan, Preeti
    Widmeyer, Maya
    Leeman, Robert F.
    Cook, Robert L.
    Canidate, Shantrel
    AIDS PATIENT CARE AND STDS, 2024, 38 (06) : 275 - 285
  • [24] Cabotegravir plus Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Sension, Michael G.
    Brunet, Laurence
    Hsu, Ricky K.
    Fusco, Jennifer S.
    Cochran, Quateka
    Uranaka, Christine
    Sridhar, Gayathri
    Vannappagari, Vani
    Van Wyk, Jean
    Mccurdy, Lewis
    Wohlfeiler, Michael B.
    Fusco, Gregory P.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (12) : 2709 - 2724
  • [25] Real World Virologic Outcomes in Patients With Elevated Body Mass Index Receiving Long Acting Cabotegravir/Rilpivirine
    Maguire, Christina
    Rueve, Kaitlyn
    Farmer, Eric
    Huesgen, Emily
    Karaj, Antoneta
    Binkley, Amanda
    Mounzer, Karam
    Brizzi, Marisa
    Chary, Pallavi
    Sung, Peter
    Graziani, Amy
    Hiserodt, Emily
    Baron, Jillian
    Koenig, Helen
    Short, William R.
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [26] Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan Area
    Nguyen, Ngan M.
    Kavanagh, Rebecca
    Gozar, Martin
    Cabral, Danielle
    Goetz, Holly
    Cha, Agnes
    Mcgowan, Joseph P.
    Pao, Megan L.
    AIDS PATIENT CARE AND STDS, 2024, 38 (03) : 115 - 122
  • [27] Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results (Sept, dkae308, 2024)
    Serris, Alexandra
    Ferre, Valentine Marie
    Le Hingrat, Quentin
    Bachelard, Antoine
    Charpentier, Charlotte
    Exarchopoulos, Marina
    Damond, Florence
    Phung, Bao-Chau
    Landman, Roland
    Yazdanpanah, Yazdan
    Descamps, Diane
    Joly, Veronique
    Peytavin, Gilles
    Ghosn, Jade
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (12) : 3370 - 3370
  • [28] Early implementation of long-acting injectable cabotegravir for HIV prevention in a safety net primary care centre in US South
    Baker, D.
    Collins, L.
    Cantos, V.
    Hollenberg, E.
    Kaplan, A.
    Cowan, T.
    Garcia, J.
    Lora, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27
  • [29] Real-world data on commercial long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror phase 3 results: Findings from a University Hospital in Paris, France
    Ferre, V. M.
    Serris, A.
    Le Hingrat, Q.
    Bachelard, A.
    Charpentier, C.
    Exarchopoulos, M.
    Digumber, M.
    Damond, F.
    Louni, F.
    Phung, B.
    Landman, R.
    Yazdanpanah, Y.
    Descamps, D.
    Joly, V.
    Peytavin, G.
    Ghosn, J.
    HIV MEDICINE, 2023, 24 : 160 - 161
  • [30] Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV
    Thoueille, Paul
    Saldanha, Susana Alves
    Schaller, Fabian
    Choong, Eva
    Veuve, Francois
    Munting, Aline
    Cavassini, Matthias
    Braun, Dominique
    Gunthard, Huldrych F.
    Duran Ramirez, Jessy J.
    Surial, Bernard
    Furrer, Hansjakob
    Rauch, Andri
    Ustero, Pilar
    Calmy, Alexandra
    Stoeckle, Marcel
    Di Benedetto, Caroline
    Bernasconi, Enos
    Schmid, Patrick
    Marzolini, Catia
    Girardin, Francois R.
    Buclin, Thierry
    Decosterd, Laurent A.
    Guidi, Monia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1450 - 1459
12345